Last updated: October 7, 2024
Sponsor: University of Alberta
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
medium chain triglyceride oil
Safflower oil
Clinical Study ID
NCT05705648
Pro00109795
Ages 22-50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
confirmed COVID infection, at least 3 months previously, with ongoing cognitivecomplaints
all other medical conditions stable, and on stable doses of medications (ifrequired)
Exclusion
Exclusion Criteria:
COVID infection not confirmed by PCR or Rapid test
unable to speak English
pre-COVID cognitve complaints, and/or medical diagnoses affecting cognitive function
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: medium chain triglyceride oil
Phase:
Study Start date:
October 01, 2023
Estimated Completion Date:
March 01, 2026
Study Description
Connect with a study center
University of Alberta
Edmonton, Alberta T6G 2P4
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.